The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ernesto Canalis

Department of Research

Saint Francis Hospital and Medical Center

114 Woodland Street

Hartford

USA

[email]@stfranciscare.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Research, Saint Francis Hospital and Medical Center, 114 Woodland Street, Hartford, USA. 2000 - 2013

References

  1. Osteoblast lineage-specific effects of notch activation in the skeleton. Canalis, E., Parker, K., Feng, J.Q., Zanotti, S. Endocrinology (2013) [Pubmed]
  2. Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Canalis, E., Brunet, L.J., Parker, K., Zanotti, S. Endocrinology (2012) [Pubmed]
  3. Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice. Canalis, E., Zanotti, S., Beamer, W.G., Economides, A.N., Smerdel-Ramoya, A. Endocrinology (2010) [Pubmed]
  4. Update in new anabolic therapies for osteoporosis. Canalis, E. J. Clin. Endocrinol. Metab. (2010) [Pubmed]
  5. New treatment modalities in osteoporosis. Canalis, E. Endocr. Pract (2010) [Pubmed]
  6. Nephroblastoma overexpressed (Nov) inactivation sensitizes osteoblasts to bone morphogenetic protein-2, but nov is dispensable for skeletal homeostasis. Canalis, E., Smerdel-Ramoya, A., Durant, D., Economides, A.N., Beamer, W.G., Zanotti, S. Endocrinology (2010) [Pubmed]
  7. Growth factor control of bone mass. Canalis, E. J. Cell. Biochem. (2009) [Pubmed]
  8. Notch signaling in osteoblasts. Canalis, E. Science. Signaling (2008) [Pubmed]
  9. Nephroblastoma overexpressed (Nov) is a novel bone morphogenetic protein antagonist. Canalis, E. Ann. N. Y. Acad. Sci. (2007) [Pubmed]
  10. Mechanisms of anabolic therapies for osteoporosis. Canalis, E., Giustina, A., Bilezikian, J.P. N. Engl. J. Med. (2007) [Pubmed]
  11. Mechanisms of glucocorticoid action in bone. Canalis, E. Curr. Osteoporos. Rep (2005) [Pubmed]
  12. Signals that determine the fate of osteoblastic cells. Canalis, E., Deregowski, V., Pereira, R.C., Gazzerro, E. J. Endocrinol. Invest. (2005) [Pubmed]
  13. Perspectives on glucocorticoid-induced osteoporosis. Canalis, E., Bilezikian, J.P., Angeli, A., Giustina, A. Bone (2004) [Pubmed]
  14. Bone morphogenetic proteins, their antagonists, and the skeleton. Canalis, E., Economides, A.N., Gazzerro, E. Endocr. Rev. (2003) [Pubmed]
  15. Mechanisms of glucocorticoid-induced osteoporosis. Canalis, E. Curr. Opin. Rheumatol (2003) [Pubmed]
  16. Mechanisms of glucocorticoid action in bone. Canalis, E., Delany, A.M. Ann. N. Y. Acad. Sci. (2002) [Pubmed]
  17. Effects of glucocorticoids on the skeleton. Canalis, E., Pereira, R.C., Delany, A.M. J. Pediatr. Endocrinol. Metab. (2002) [Pubmed]
  18. Glucocorticoid-induced osteoporosis: summary of a workshop. Canalis, E., Giustina, A. J. Clin. Endocrinol. Metab. (2001) [Pubmed]
  19. Novel treatments for osteoporosis. Canalis, E. J. Clin. Invest. (2000) [Pubmed]
 
WikiGenes - Universities